IL108384A - 3-Noble-2-oxindole-1-oxindole-1-carboxoxamide anti-inflammatory drugs and uses thereof - Google Patents
3-Noble-2-oxindole-1-oxindole-1-carboxoxamide anti-inflammatory drugs and uses thereofInfo
- Publication number
- IL108384A IL108384A IL10838494A IL10838494A IL108384A IL 108384 A IL108384 A IL 108384A IL 10838494 A IL10838494 A IL 10838494A IL 10838494 A IL10838494 A IL 10838494A IL 108384 A IL108384 A IL 108384A
- Authority
- IL
- Israel
- Prior art keywords
- alkyl
- compound
- chloro
- optionally substituted
- fluoro
- Prior art date
Links
- 229940002612 prodrug Drugs 0.000 title abstract description 18
- 239000000651 prodrug Substances 0.000 title abstract description 18
- 125000000217 alkyl group Chemical group 0.000 claims abstract description 44
- 229910052739 hydrogen Inorganic materials 0.000 claims abstract description 33
- 239000001257 hydrogen Substances 0.000 claims abstract description 18
- 150000002431 hydrogen Chemical class 0.000 claims abstract description 13
- 229910052736 halogen Inorganic materials 0.000 claims abstract description 10
- 150000002367 halogens Chemical class 0.000 claims abstract description 10
- 150000001875 compounds Chemical class 0.000 claims description 122
- -1 C3-C7 cycloalkyi Chemical group 0.000 claims description 54
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 claims description 46
- 238000002360 preparation method Methods 0.000 claims description 44
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 claims description 18
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 claims description 15
- 125000001424 substituent group Chemical group 0.000 claims description 15
- RWRDLPDLKQPQOW-UHFFFAOYSA-N Pyrrolidine Chemical group C1CCNC1 RWRDLPDLKQPQOW-UHFFFAOYSA-N 0.000 claims description 14
- 239000003814 drug Substances 0.000 claims description 13
- 125000001797 benzyl group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])* 0.000 claims description 9
- 229910052799 carbon Inorganic materials 0.000 claims description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 8
- 241000124008 Mammalia Species 0.000 claims description 8
- NQRYJNQNLNOLGT-UHFFFAOYSA-N Piperidine Chemical group C1CCNCC1 NQRYJNQNLNOLGT-UHFFFAOYSA-N 0.000 claims description 8
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 claims description 8
- 125000003545 alkoxy group Chemical group 0.000 claims description 7
- 101150047265 COR2 gene Chemical group 0.000 claims description 6
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical group C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 claims description 6
- 101100467189 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) QCR2 gene Chemical group 0.000 claims description 6
- 125000002947 alkylene group Chemical group 0.000 claims description 6
- ZSIQJIWKELUFRJ-UHFFFAOYSA-N azepane Chemical group C1CCCNCC1 ZSIQJIWKELUFRJ-UHFFFAOYSA-N 0.000 claims description 6
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 claims description 6
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 claims description 6
- 206010061218 Inflammation Diseases 0.000 claims description 5
- 125000004051 hexyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 claims description 5
- 230000004054 inflammatory process Effects 0.000 claims description 5
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 claims description 4
- 229910052757 nitrogen Inorganic materials 0.000 claims description 4
- 229910052760 oxygen Inorganic materials 0.000 claims description 4
- 125000000882 C2-C6 alkenyl group Chemical group 0.000 claims description 3
- 125000003187 heptyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 claims description 3
- 125000004105 2-pyridyl group Chemical group N1=C([*])C([H])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000003349 3-pyridyl group Chemical group N1=C([H])C([*])=C([H])C([H])=C1[H] 0.000 claims description 2
- 125000000339 4-pyridyl group Chemical group N1=C([H])C([H])=C([*])C([H])=C1[H] 0.000 claims description 2
- DHXVGJBLRPWPCS-UHFFFAOYSA-N Tetrahydropyran Chemical compound C1CCOCC1 DHXVGJBLRPWPCS-UHFFFAOYSA-N 0.000 claims description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 claims description 2
- 125000000392 cycloalkenyl group Chemical group 0.000 claims description 2
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 claims description 2
- 150000003951 lactams Chemical group 0.000 claims description 2
- AHHWIHXENZJRFG-UHFFFAOYSA-N oxetane Chemical compound C1COC1 AHHWIHXENZJRFG-UHFFFAOYSA-N 0.000 claims description 2
- 239000001301 oxygen Substances 0.000 claims description 2
- 125000000843 phenylene group Chemical group C1(=C(C=CC=C1)*)* 0.000 claims description 2
- 125000004483 piperidin-3-yl group Chemical group N1CC(CCC1)* 0.000 claims description 2
- 125000004482 piperidin-4-yl group Chemical group N1CCC(CC1)* 0.000 claims description 2
- 229910052717 sulfur Inorganic materials 0.000 claims description 2
- 125000000753 cycloalkyl group Chemical group 0.000 claims 5
- 125000004485 2-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])([H])C1([H])* 0.000 claims 1
- 125000004575 3-pyrrolidinyl group Chemical group [H]N1C([H])([H])C([H])([H])C([H])(*)C1([H])[H] 0.000 claims 1
- 125000000686 lactone group Chemical group 0.000 claims 1
- 230000003110 anti-inflammatory effect Effects 0.000 abstract description 5
- 230000000202 analgesic effect Effects 0.000 abstract description 3
- PCKPVGOLPKLUHR-UHFFFAOYSA-N OH-Indolxyl Natural products C1=CC=C2C(O)=CNC2=C1 PCKPVGOLPKLUHR-UHFFFAOYSA-N 0.000 abstract 1
- JYGFTBXVXVMTGB-UHFFFAOYSA-N indolin-2-one Chemical compound C1=CC=C2NC(=O)CC2=C1 JYGFTBXVXVMTGB-UHFFFAOYSA-N 0.000 abstract 1
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 189
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 186
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 168
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 118
- 239000007787 solid Substances 0.000 description 105
- 239000000243 solution Substances 0.000 description 96
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 89
- 239000003921 oil Substances 0.000 description 88
- 235000019198 oils Nutrition 0.000 description 88
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 82
- 239000000203 mixture Substances 0.000 description 76
- 235000019439 ethyl acetate Nutrition 0.000 description 69
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 62
- FVAUCKIRQBBSSJ-UHFFFAOYSA-M sodium iodide Chemical compound [Na+].[I-] FVAUCKIRQBBSSJ-UHFFFAOYSA-M 0.000 description 60
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 58
- 238000000034 method Methods 0.000 description 50
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 50
- JGFZNNIVVJXRND-UHFFFAOYSA-N N,N-Diisopropylethylamine (DIPEA) Chemical compound CCN(C(C)C)C(C)C JGFZNNIVVJXRND-UHFFFAOYSA-N 0.000 description 47
- 239000000047 product Substances 0.000 description 47
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 44
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 39
- 239000000741 silica gel Substances 0.000 description 37
- 229910002027 silica gel Inorganic materials 0.000 description 37
- 239000012043 crude product Substances 0.000 description 36
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 31
- 239000002904 solvent Substances 0.000 description 31
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 29
- 238000001914 filtration Methods 0.000 description 29
- 229910052938 sodium sulfate Inorganic materials 0.000 description 29
- 235000011152 sodium sulphate Nutrition 0.000 description 29
- 239000010410 layer Substances 0.000 description 27
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 26
- JPOXNPPZZKNXOV-UHFFFAOYSA-N bromochloromethane Chemical compound ClCBr JPOXNPPZZKNXOV-UHFFFAOYSA-N 0.000 description 26
- 238000002425 crystallisation Methods 0.000 description 24
- 230000008025 crystallization Effects 0.000 description 24
- 239000002253 acid Substances 0.000 description 23
- 239000000706 filtrate Substances 0.000 description 23
- 238000003756 stirring Methods 0.000 description 22
- YXFVVABEGXRONW-UHFFFAOYSA-N Toluene Chemical compound CC1=CC=CC=C1 YXFVVABEGXRONW-UHFFFAOYSA-N 0.000 description 21
- 238000001704 evaporation Methods 0.000 description 21
- 230000008020 evaporation Effects 0.000 description 21
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 20
- 238000000746 purification Methods 0.000 description 20
- 235000009518 sodium iodide Nutrition 0.000 description 20
- 238000003818 flash chromatography Methods 0.000 description 19
- 239000000725 suspension Substances 0.000 description 19
- 238000001953 recrystallisation Methods 0.000 description 18
- 238000010828 elution Methods 0.000 description 17
- 239000000523 sample Substances 0.000 description 16
- SPQNPQCUZPOZJX-UHFFFAOYSA-N 6-chloro-5-fluoro-2-hydroxy-3-(thiophene-2-carbonyl)indole-1-carboxamide Chemical compound C12=CC(F)=C(Cl)C=C2N(C(=O)N)C(O)=C1C(=O)C1=CC=CS1 SPQNPQCUZPOZJX-UHFFFAOYSA-N 0.000 description 15
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- SHFJWMWCIHQNCP-UHFFFAOYSA-M hydron;tetrabutylazanium;sulfate Chemical compound OS([O-])(=O)=O.CCCC[N+](CCCC)(CCCC)CCCC SHFJWMWCIHQNCP-UHFFFAOYSA-M 0.000 description 15
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 14
- 238000006243 chemical reaction Methods 0.000 description 14
- 239000011541 reaction mixture Substances 0.000 description 14
- 125000004432 carbon atom Chemical group C* 0.000 description 13
- 238000001816 cooling Methods 0.000 description 13
- DZLFLBLQUQXARW-UHFFFAOYSA-N tetrabutylammonium Chemical class CCCC[N+](CCCC)(CCCC)CCCC DZLFLBLQUQXARW-UHFFFAOYSA-N 0.000 description 13
- 238000004587 chromatography analysis Methods 0.000 description 12
- 239000002244 precipitate Substances 0.000 description 12
- 238000010992 reflux Methods 0.000 description 11
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 10
- ROSDSFDQCJNGOL-UHFFFAOYSA-N Dimethylamine Chemical compound CNC ROSDSFDQCJNGOL-UHFFFAOYSA-N 0.000 description 9
- SJRJJKPEHAURKC-UHFFFAOYSA-N N-Methylmorpholine Chemical compound CN1CCOCC1 SJRJJKPEHAURKC-UHFFFAOYSA-N 0.000 description 9
- 238000001035 drying Methods 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 9
- 239000000377 silicon dioxide Substances 0.000 description 9
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 8
- 238000005481 NMR spectroscopy Methods 0.000 description 8
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 8
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 8
- 239000000463 material Substances 0.000 description 8
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 8
- 239000010502 orange oil Substances 0.000 description 8
- 150000003839 salts Chemical group 0.000 description 8
- 159000000000 sodium salts Chemical class 0.000 description 8
- JIAARYAFYJHUJI-UHFFFAOYSA-L zinc dichloride Chemical compound [Cl-].[Cl-].[Zn+2] JIAARYAFYJHUJI-UHFFFAOYSA-L 0.000 description 8
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 7
- 235000017557 sodium bicarbonate Nutrition 0.000 description 7
- DTQVDTLACAAQTR-UHFFFAOYSA-N trifluoroacetic acid Substances OC(=O)C(F)(F)F DTQVDTLACAAQTR-UHFFFAOYSA-N 0.000 description 7
- CVFDJASAXYQBMX-UHFFFAOYSA-N 2-trimethylsilylethyl 4-chloro-4-oxobut-2-enoate Chemical compound C[Si](C)(C)CCOC(=O)C=CC(Cl)=O CVFDJASAXYQBMX-UHFFFAOYSA-N 0.000 description 6
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 6
- WVDDGKGOMKODPV-UHFFFAOYSA-N Benzyl alcohol Chemical compound OCC1=CC=CC=C1 WVDDGKGOMKODPV-UHFFFAOYSA-N 0.000 description 6
- 235000019502 Orange oil Nutrition 0.000 description 6
- 239000000284 extract Substances 0.000 description 6
- 239000005457 ice water Substances 0.000 description 6
- 239000012044 organic layer Substances 0.000 description 6
- 125000005740 oxycarbonyl group Chemical group [*:1]OC([*:2])=O 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 238000000425 proton nuclear magnetic resonance spectrum Methods 0.000 description 6
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 6
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 5
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 5
- 125000000051 benzyloxy group Chemical group [H]C1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])O* 0.000 description 5
- SKCNIGRBPJIUBQ-UHFFFAOYSA-N chloroform;ethyl acetate Chemical compound ClC(Cl)Cl.CCOC(C)=O SKCNIGRBPJIUBQ-UHFFFAOYSA-N 0.000 description 5
- 239000013078 crystal Substances 0.000 description 5
- 238000002844 melting Methods 0.000 description 5
- 230000008018 melting Effects 0.000 description 5
- 239000011734 sodium Substances 0.000 description 5
- 229910052708 sodium Inorganic materials 0.000 description 5
- AKHNMLFCWUSKQB-UHFFFAOYSA-L sodium thiosulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=S AKHNMLFCWUSKQB-UHFFFAOYSA-L 0.000 description 5
- 235000019345 sodium thiosulphate Nutrition 0.000 description 5
- 239000007858 starting material Substances 0.000 description 5
- FALRKNHUBBKYCC-UHFFFAOYSA-N 2-(chloromethyl)pyridine-3-carbonitrile Chemical compound ClCC1=NC=CC=C1C#N FALRKNHUBBKYCC-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 4
- AFVFQIVMOAPDHO-UHFFFAOYSA-N Methanesulfonic acid Chemical compound CS(O)(=O)=O AFVFQIVMOAPDHO-UHFFFAOYSA-N 0.000 description 4
- HNTOXOODVYFYDL-UHFFFAOYSA-M [Na+].[NH-]C(=O)N1C(=O)C(=C(O)c2cccs2)c2cc(F)c(Cl)cc12 Chemical compound [Na+].[NH-]C(=O)N1C(=O)C(=C(O)c2cccs2)c2cc(F)c(Cl)cc12 HNTOXOODVYFYDL-UHFFFAOYSA-M 0.000 description 4
- QOPVNWQGBQYBBP-UHFFFAOYSA-N chloroethyl chloroformate Chemical compound CC(Cl)OC(Cl)=O QOPVNWQGBQYBBP-UHFFFAOYSA-N 0.000 description 4
- OAYLNYINCPYISS-UHFFFAOYSA-N ethyl acetate;hexane Chemical compound CCCCCC.CCOC(C)=O OAYLNYINCPYISS-UHFFFAOYSA-N 0.000 description 4
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 4
- 235000019341 magnesium sulphate Nutrition 0.000 description 4
- GRJJQCWNZGRKAU-UHFFFAOYSA-N pyridin-1-ium;fluoride Chemical compound F.C1=CC=NC=C1 GRJJQCWNZGRKAU-UHFFFAOYSA-N 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 4
- 229920006395 saturated elastomer Polymers 0.000 description 4
- 229940014800 succinic anhydride Drugs 0.000 description 4
- 238000001665 trituration Methods 0.000 description 4
- 235000005074 zinc chloride Nutrition 0.000 description 4
- 239000011592 zinc chloride Substances 0.000 description 4
- HZDNNJABYXNPPV-UHFFFAOYSA-N (2-chloro-2-oxoethyl) acetate Chemical compound CC(=O)OCC(Cl)=O HZDNNJABYXNPPV-UHFFFAOYSA-N 0.000 description 3
- ZLYYJUJDFKGVKB-OWOJBTEDSA-N (e)-but-2-enedioyl dichloride Chemical compound ClC(=O)\C=C\C(Cl)=O ZLYYJUJDFKGVKB-OWOJBTEDSA-N 0.000 description 3
- TVRDZOYLTRJNII-UHFFFAOYSA-N 2-(2-ethoxy-2-oxoethoxy)acetic acid Chemical compound CCOC(=O)COCC(O)=O TVRDZOYLTRJNII-UHFFFAOYSA-N 0.000 description 3
- DYLIIGBRGWUCEP-UHFFFAOYSA-N 2-(2-oxo-2-phenylmethoxyethoxy)acetic acid Chemical compound OC(=O)COCC(=O)OCC1=CC=CC=C1 DYLIIGBRGWUCEP-UHFFFAOYSA-N 0.000 description 3
- 125000000175 2-thienyl group Chemical group S1C([*])=C([H])C([H])=C1[H] 0.000 description 3
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 3
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 3
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 150000003862 amino acid derivatives Chemical class 0.000 description 3
- 239000002260 anti-inflammatory agent Substances 0.000 description 3
- 239000012267 brine Substances 0.000 description 3
- 239000003054 catalyst Substances 0.000 description 3
- 230000003197 catalytic effect Effects 0.000 description 3
- 125000001309 chloro group Chemical group Cl* 0.000 description 3
- 125000004218 chloromethyl group Chemical group [H]C([H])(Cl)* 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000005690 diesters Chemical class 0.000 description 3
- 238000004821 distillation Methods 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 239000012259 ether extract Substances 0.000 description 3
- YYLWXDIGYFPUSK-UHFFFAOYSA-N ethyl 4-chloro-4-oxobut-2-enoate Chemical compound CCOC(=O)C=CC(Cl)=O YYLWXDIGYFPUSK-UHFFFAOYSA-N 0.000 description 3
- 239000000543 intermediate Substances 0.000 description 3
- BPVXIVSZMMKCCD-UHFFFAOYSA-N methyl 2-(1-chloroethoxycarbonyloxy)acetate Chemical compound COC(=O)COC(=O)OC(C)Cl BPVXIVSZMMKCCD-UHFFFAOYSA-N 0.000 description 3
- 238000012986 modification Methods 0.000 description 3
- 230000004048 modification Effects 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- 239000002002 slurry Substances 0.000 description 3
- HPALAKNZSZLMCH-UHFFFAOYSA-M sodium;chloride;hydrate Chemical compound O.[Na+].[Cl-] HPALAKNZSZLMCH-UHFFFAOYSA-M 0.000 description 3
- 238000012360 testing method Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- RYHBNJHYFVUHQT-UHFFFAOYSA-N 1,4-Dioxane Chemical compound C1COCCO1 RYHBNJHYFVUHQT-UHFFFAOYSA-N 0.000 description 2
- PIYNUZCGMLCXKJ-UHFFFAOYSA-N 1,4-dioxane-2,6-dione Chemical compound O=C1COCC(=O)O1 PIYNUZCGMLCXKJ-UHFFFAOYSA-N 0.000 description 2
- QUXXOXOXAVOFBT-UHFFFAOYSA-N 1-chloroethyl [2-(diethylamino)-2-oxoethyl] carbonate Chemical compound CCN(CC)C(=O)COC(=O)OC(C)Cl QUXXOXOXAVOFBT-UHFFFAOYSA-N 0.000 description 2
- RXTDNNAGJGWPKM-UHFFFAOYSA-N 1-chloroethyl [2-(dimethylamino)-2-oxoethyl] carbonate Chemical compound CC(Cl)OC(=O)OCC(=O)N(C)C RXTDNNAGJGWPKM-UHFFFAOYSA-N 0.000 description 2
- AJBNGICEKLFKLM-UHFFFAOYSA-N 2,2,2-trichloroethyl 3-carbonochloridoylbenzoate Chemical compound ClC(=O)C1=CC=CC(C(=O)OCC(Cl)(Cl)Cl)=C1 AJBNGICEKLFKLM-UHFFFAOYSA-N 0.000 description 2
- GIUTUZDGHNZVIA-UHFFFAOYSA-N 2-(ethylamino)acetic acid;hydrochloride Chemical compound Cl.CCNCC(O)=O GIUTUZDGHNZVIA-UHFFFAOYSA-N 0.000 description 2
- JJKWHOSQTYYFAE-UHFFFAOYSA-N 2-methoxyacetyl chloride Chemical compound COCC(Cl)=O JJKWHOSQTYYFAE-UHFFFAOYSA-N 0.000 description 2
- MSHFRERJPWKJFX-UHFFFAOYSA-N 4-Methoxybenzyl alcohol Chemical compound COC1=CC=C(CO)C=C1 MSHFRERJPWKJFX-UHFFFAOYSA-N 0.000 description 2
- UGUBQKZSNQWWEV-UHFFFAOYSA-N 4-oxo-4-phenylmethoxybutanoic acid Chemical compound OC(=O)CCC(=O)OCC1=CC=CC=C1 UGUBQKZSNQWWEV-UHFFFAOYSA-N 0.000 description 2
- QTSPMCBUVDLSIO-UHFFFAOYSA-N 4-phenylbutyl 4-chloro-4-oxobut-2-enoate Chemical compound ClC(=O)C=CC(=O)OCCCCC1=CC=CC=C1 QTSPMCBUVDLSIO-UHFFFAOYSA-N 0.000 description 2
- OGHIPGQBGXVODR-UHFFFAOYSA-N 6-chloro-5-fluoro-3-[hydroxy(thiophen-2-yl)methylidene]-2-oxoindole-1-carboxamide;sodium Chemical compound [Na].C12=CC(F)=C(Cl)C=C2N(C(=O)N)C(=O)C1=C(O)C1=CC=CS1 OGHIPGQBGXVODR-UHFFFAOYSA-N 0.000 description 2
- IAZDPXIOMUYVGZ-WFGJKAKNSA-N Dimethyl sulfoxide Chemical compound [2H]C([2H])([2H])S(=O)C([2H])([2H])[2H] IAZDPXIOMUYVGZ-WFGJKAKNSA-N 0.000 description 2
- 102000003820 Lipoxygenases Human genes 0.000 description 2
- 108090000128 Lipoxygenases Proteins 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-M Propionate Chemical compound CCC([O-])=O XBDQKXXYIPTUBI-UHFFFAOYSA-M 0.000 description 2
- 102000004005 Prostaglandin-endoperoxide synthases Human genes 0.000 description 2
- 108090000459 Prostaglandin-endoperoxide synthases Proteins 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- XJVHQXIBOSUJRY-UHFFFAOYSA-N [2-(dimethylamino)-2-oxoethyl] 1-iodoethyl carbonate Chemical compound CC(I)OC(=O)OCC(=O)N(C)C XJVHQXIBOSUJRY-UHFFFAOYSA-N 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000002378 acidificating effect Effects 0.000 description 2
- 150000007513 acids Chemical class 0.000 description 2
- 229910052783 alkali metal Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000003242 anti bacterial agent Substances 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- OADZZKGIPRHHFN-UHFFFAOYSA-N benzyl 4-carbonochloridoylbenzoate Chemical compound C1=CC(C(=O)Cl)=CC=C1C(=O)OCC1=CC=CC=C1 OADZZKGIPRHHFN-UHFFFAOYSA-N 0.000 description 2
- 235000019445 benzyl alcohol Nutrition 0.000 description 2
- 230000015572 biosynthetic process Effects 0.000 description 2
- SRILLQIXUPLJLV-UHFFFAOYSA-N butyl 4-chloro-4-oxobut-2-enoate Chemical compound CCCCOC(=O)C=CC(Cl)=O SRILLQIXUPLJLV-UHFFFAOYSA-N 0.000 description 2
- 125000001589 carboacyl group Chemical group 0.000 description 2
- WORJEOGGNQDSOE-UHFFFAOYSA-N chloroform;methanol Chemical compound OC.ClC(Cl)Cl WORJEOGGNQDSOE-UHFFFAOYSA-N 0.000 description 2
- 239000012230 colorless oil Substances 0.000 description 2
- HPNMFZURTQLUMO-UHFFFAOYSA-N diethylamine Chemical compound CCNCC HPNMFZURTQLUMO-UHFFFAOYSA-N 0.000 description 2
- XBDQKXXYIPTUBI-UHFFFAOYSA-N dimethylselenoniopropionate Natural products CCC(O)=O XBDQKXXYIPTUBI-UHFFFAOYSA-N 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 230000002496 gastric effect Effects 0.000 description 2
- QAOWNCQODCNURD-UHFFFAOYSA-M hydrogensulfate Chemical compound OS([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-M 0.000 description 2
- 125000002346 iodo group Chemical group I* 0.000 description 2
- INQOMBQAUSQDDS-UHFFFAOYSA-N iodomethane Chemical compound IC INQOMBQAUSQDDS-UHFFFAOYSA-N 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- 239000004310 lactic acid Substances 0.000 description 2
- 235000014655 lactic acid Nutrition 0.000 description 2
- VBKLZZJIEBSFPB-UHFFFAOYSA-N methyl 2-(1-iodoethoxycarbonyloxy)acetate Chemical compound COC(=O)COC(=O)OC(C)I VBKLZZJIEBSFPB-UHFFFAOYSA-N 0.000 description 2
- DUWWHGPELOTTOE-UHFFFAOYSA-N n-(5-chloro-2,4-dimethoxyphenyl)-3-oxobutanamide Chemical compound COC1=CC(OC)=C(NC(=O)CC(C)=O)C=C1Cl DUWWHGPELOTTOE-UHFFFAOYSA-N 0.000 description 2
- 229940021182 non-steroidal anti-inflammatory drug Drugs 0.000 description 2
- KWZOTMBAZFCRQC-UHFFFAOYSA-N octyl 4-chloro-4-oxobut-2-enoate Chemical compound CCCCCCCCOC(=O)C=CC(Cl)=O KWZOTMBAZFCRQC-UHFFFAOYSA-N 0.000 description 2
- CTSLXHKWHWQRSH-UHFFFAOYSA-N oxalyl chloride Chemical compound ClC(=O)C(Cl)=O CTSLXHKWHWQRSH-UHFFFAOYSA-N 0.000 description 2
- RZWZRACFZGVKFM-UHFFFAOYSA-N propanoyl chloride Chemical compound CCC(Cl)=O RZWZRACFZGVKFM-UHFFFAOYSA-N 0.000 description 2
- 235000019260 propionic acid Nutrition 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 150000003512 tertiary amines Chemical class 0.000 description 2
- GETQZCLCWQTVFV-UHFFFAOYSA-N trimethylamine Chemical compound CN(C)C GETQZCLCWQTVFV-UHFFFAOYSA-N 0.000 description 2
- NQPDZGIKBAWPEJ-UHFFFAOYSA-N valeric acid Chemical compound CCCCC(O)=O NQPDZGIKBAWPEJ-UHFFFAOYSA-N 0.000 description 2
- 238000010792 warming Methods 0.000 description 2
- RLWFMZKPPHHHCB-PWNYCUMCSA-N (1r,2r)-cyclopropane-1,2-dicarboxylic acid Chemical compound OC(=O)[C@@H]1C[C@H]1C(O)=O RLWFMZKPPHHHCB-PWNYCUMCSA-N 0.000 description 1
- YBXOZAUEPYYUOH-UHFFFAOYSA-N (4-methoxyphenyl)methyl 2-[1-[2-(chloromethoxy)-2-oxoethyl]cyclopentyl]acetate Chemical compound C1=CC(OC)=CC=C1COC(=O)CC1(CC(=O)OCCl)CCCC1 YBXOZAUEPYYUOH-UHFFFAOYSA-N 0.000 description 1
- WOGITNXCNOTRLK-VOTSOKGWSA-N (e)-3-phenylprop-2-enoyl chloride Chemical compound ClC(=O)\C=C\C1=CC=CC=C1 WOGITNXCNOTRLK-VOTSOKGWSA-N 0.000 description 1
- ZQZLGXFRUOJTCE-UHFFFAOYSA-N 1,3-dioxane-5-carboxylic acid Chemical compound OC(=O)C1COCOC1 ZQZLGXFRUOJTCE-UHFFFAOYSA-N 0.000 description 1
- NILQLFBWTXNUOE-UHFFFAOYSA-N 1-aminocyclopentanecarboxylic acid Chemical compound OC(=O)C1(N)CCCC1 NILQLFBWTXNUOE-UHFFFAOYSA-N 0.000 description 1
- LNYVOAYJZFDVKI-UHFFFAOYSA-N 1-chloroethyl carbonochloridate propan-2-yl hydrogen carbonate Chemical compound ClC(=O)OC(C)Cl.C(OC(C)C)(O)=O LNYVOAYJZFDVKI-UHFFFAOYSA-N 0.000 description 1
- XZVBIIRIWFZJOE-UHFFFAOYSA-N 1-iodoethyl propan-2-yl carbonate Chemical compound CC(C)OC(=O)OC(C)I XZVBIIRIWFZJOE-UHFFFAOYSA-N 0.000 description 1
- SJYKZGKHXIHXFD-UHFFFAOYSA-N 1-o-benzyl 4-o-(1-chloroethyl) benzene-1,4-dicarboxylate Chemical compound C1=CC(C(=O)OC(Cl)C)=CC=C1C(=O)OCC1=CC=CC=C1 SJYKZGKHXIHXFD-UHFFFAOYSA-N 0.000 description 1
- 238000005160 1H NMR spectroscopy Methods 0.000 description 1
- KPWDGTGXUYRARH-UHFFFAOYSA-N 2,2,2-trichloroethanol Chemical compound OCC(Cl)(Cl)Cl KPWDGTGXUYRARH-UHFFFAOYSA-N 0.000 description 1
- JVSFQJZRHXAUGT-UHFFFAOYSA-N 2,2-dimethylpropanoyl chloride Chemical compound CC(C)(C)C(Cl)=O JVSFQJZRHXAUGT-UHFFFAOYSA-N 0.000 description 1
- WYBPOIJTBSCBSH-UHFFFAOYSA-N 2-(2-ethylbutanoylamino)acetic acid Chemical compound CCC(CC)C(=O)NCC(O)=O WYBPOIJTBSCBSH-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- QEVGZEDELICMKH-UHFFFAOYSA-L 2-(carboxylatomethoxy)acetate Chemical compound [O-]C(=O)COCC([O-])=O QEVGZEDELICMKH-UHFFFAOYSA-L 0.000 description 1
- QJFCODYYZLBLEV-UHFFFAOYSA-N 2-[1-[2-[(4-methoxyphenyl)methoxy]-2-oxoethyl]cyclopentyl]acetic acid Chemical compound C1=CC(OC)=CC=C1COC(=O)CC1(CC(O)=O)CCCC1 QJFCODYYZLBLEV-UHFFFAOYSA-N 0.000 description 1
- SUGJWVAZTHDYAA-UHFFFAOYSA-N 2-[2-(diethylamino)-2-oxoethoxy]acetyl chloride Chemical compound CCN(CC)C(=O)COCC(Cl)=O SUGJWVAZTHDYAA-UHFFFAOYSA-N 0.000 description 1
- CQQUWTMMFMJEFE-UHFFFAOYSA-N 2-chloro-n,n-diethylacetamide Chemical compound CCN(CC)C(=O)CCl CQQUWTMMFMJEFE-UHFFFAOYSA-N 0.000 description 1
- YCURDTPXHPXCKH-UHFFFAOYSA-N 2-ethylbutanoyl 2-ethylbutanoate Chemical compound CCC(CC)C(=O)OC(=O)C(CC)CC YCURDTPXHPXCKH-UHFFFAOYSA-N 0.000 description 1
- OFTKFKYVSBNYEC-UHFFFAOYSA-N 2-furoyl chloride Chemical compound ClC(=O)C1=CC=CO1 OFTKFKYVSBNYEC-UHFFFAOYSA-N 0.000 description 1
- JNQVLKWNKVMFBN-UHFFFAOYSA-N 2-hydroxy-n,n-dimethylacetamide Chemical compound CN(C)C(=O)CO JNQVLKWNKVMFBN-UHFFFAOYSA-N 0.000 description 1
- RZNHSEZOLFEFGB-UHFFFAOYSA-N 2-methoxybenzoyl chloride Chemical compound COC1=CC=CC=C1C(Cl)=O RZNHSEZOLFEFGB-UHFFFAOYSA-N 0.000 description 1
- UYINJAQCJCYCGO-UHFFFAOYSA-N 2-oxo-3h-indole-1-carboxamide Chemical compound C1=CC=C2N(C(=O)N)C(=O)CC2=C1 UYINJAQCJCYCGO-UHFFFAOYSA-N 0.000 description 1
- RLQZIECDMISZHS-UHFFFAOYSA-N 2-phenylcyclohexa-2,5-diene-1,4-dione Chemical compound O=C1C=CC(=O)C(C=2C=CC=CC=2)=C1 RLQZIECDMISZHS-UHFFFAOYSA-N 0.000 description 1
- QISAUDWTBBNJIR-UHFFFAOYSA-N 2-phenylmethoxyacetyl chloride Chemical compound ClC(=O)COCC1=CC=CC=C1 QISAUDWTBBNJIR-UHFFFAOYSA-N 0.000 description 1
- ZNGINKJHQQQORD-UHFFFAOYSA-N 2-trimethylsilylethanol Chemical compound C[Si](C)(C)CCO ZNGINKJHQQQORD-UHFFFAOYSA-N 0.000 description 1
- XAVPAZWJHKOUGL-RKDXNWHRSA-N 2-trimethylsilylethyl (1r,2r)-2-carbonochloridoylcyclobutane-1-carboxylate Chemical compound C[Si](C)(C)CCOC(=O)[C@@H]1CC[C@H]1C(Cl)=O XAVPAZWJHKOUGL-RKDXNWHRSA-N 0.000 description 1
- DFUUOVFWQVGFIV-UHFFFAOYSA-N 3-[(1-carbamoyl-6-chloro-5-fluoro-2-oxoindol-3-ylidene)-thiophen-2-ylmethoxy]carbonylbenzoic acid Chemical compound C12=CC(F)=C(Cl)C=C2N(C(=O)N)C(=O)C1=C(C=1SC=CC=1)OC(=O)C1=CC=CC(C(O)=O)=C1 DFUUOVFWQVGFIV-UHFFFAOYSA-N 0.000 description 1
- RUQIUASLAXJZIE-UHFFFAOYSA-N 3-methoxybenzoyl chloride Chemical compound COC1=CC=CC(C(Cl)=O)=C1 RUQIUASLAXJZIE-UHFFFAOYSA-N 0.000 description 1
- YCZJYDRVADSBFF-UHFFFAOYSA-N 4-(dipropylamino)-4-oxobutanoate;dipropylazanium Chemical compound CCC[NH2+]CCC.CCCN(CCC)C(=O)CCC([O-])=O YCZJYDRVADSBFF-UHFFFAOYSA-N 0.000 description 1
- 125000004217 4-methoxybenzyl group Chemical group [H]C1=C([H])C(=C([H])C([H])=C1OC([H])([H])[H])C([H])([H])* 0.000 description 1
- SOJBWVUXQHXQDT-UHFFFAOYSA-M 5-oxo-5-phenylmethoxypentanoate;tetrabutylazanium Chemical compound [O-]C(=O)CCCC(=O)OCC1=CC=CC=C1.CCCC[N+](CCCC)(CCCC)CCCC SOJBWVUXQHXQDT-UHFFFAOYSA-M 0.000 description 1
- RQPSIRZEVZUYOF-UHFFFAOYSA-N 6-chloro-3-[(4-chlorothiophen-2-yl)-hydroxymethylidene]-5-fluoro-2-oxoindole-1-carboxamide Chemical compound C12=CC(F)=C(Cl)C=C2N(C(=O)N)C(=O)C1=C(O)C1=CC(Cl)=CS1 RQPSIRZEVZUYOF-UHFFFAOYSA-N 0.000 description 1
- BVNJBATUHVXZKP-UHFFFAOYSA-N 6-chloro-5-fluoro-3-[hydroxy(thiophen-2-yl)methylidene]-2-oxoindole-1-carboxamide Chemical compound C12=CC(F)=C(Cl)C=C2N(C(=O)N)C(=O)C1=C(O)C1=CC=CS1 BVNJBATUHVXZKP-UHFFFAOYSA-N 0.000 description 1
- GFWLMILMVMCJDI-UHFFFAOYSA-N 8-oxaspiro[4.5]decane-7,9-dione Chemical compound C1C(=O)OC(=O)CC11CCCC1 GFWLMILMVMCJDI-UHFFFAOYSA-N 0.000 description 1
- 206010067484 Adverse reaction Diseases 0.000 description 1
- DHMQDGOQFOQNFH-UHFFFAOYSA-M Aminoacetate Chemical compound NCC([O-])=O DHMQDGOQFOQNFH-UHFFFAOYSA-M 0.000 description 1
- CPELXLSAUQHCOX-UHFFFAOYSA-M Bromide Chemical compound [Br-] CPELXLSAUQHCOX-UHFFFAOYSA-M 0.000 description 1
- 208000030453 Drug-Related Side Effects and Adverse reaction Diseases 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 206010053155 Epigastric discomfort Diseases 0.000 description 1
- 241000400611 Eucalyptus deanei Species 0.000 description 1
- 208000009386 Experimental Arthritis Diseases 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 239000005909 Kieselgur Substances 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- 206010030124 Oedema peripheral Diseases 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical class [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
- 239000004133 Sodium thiosulphate Substances 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- QGBIYSBAZUXFER-UHFFFAOYSA-N [2-(diethylamino)-2-oxoethyl] 1-iodoethyl carbonate Chemical compound CCN(CC)C(=O)COC(=O)OC(C)I QGBIYSBAZUXFER-UHFFFAOYSA-N 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 230000006838 adverse reaction Effects 0.000 description 1
- 125000003342 alkenyl group Chemical group 0.000 description 1
- 125000004453 alkoxycarbonyl group Chemical group 0.000 description 1
- 150000003973 alkyl amines Chemical class 0.000 description 1
- 125000004390 alkyl sulfonyl group Chemical group 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- 239000000538 analytical sample Substances 0.000 description 1
- MXMOTZIXVICDSD-UHFFFAOYSA-N anisoyl chloride Chemical compound COC1=CC=C(C(Cl)=O)C=C1 MXMOTZIXVICDSD-UHFFFAOYSA-N 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- FDQSRULYDNDXQB-UHFFFAOYSA-N benzene-1,3-dicarbonyl chloride Chemical compound ClC(=O)C1=CC=CC(C(Cl)=O)=C1 FDQSRULYDNDXQB-UHFFFAOYSA-N 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 125000001246 bromo group Chemical group Br* 0.000 description 1
- GMVYVHVFYLKIGJ-UHFFFAOYSA-N butan-2-yl 4-chloro-4-oxobut-2-enoate Chemical compound CCC(C)OC(=O)C=CC(Cl)=O GMVYVHVFYLKIGJ-UHFFFAOYSA-N 0.000 description 1
- 239000006227 byproduct Substances 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 239000002026 chloroform extract Substances 0.000 description 1
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 1
- MYFWDKSISWGFHK-UHFFFAOYSA-N chloromethyl 2-(2,2-dimethylpropanoylamino)acetate Chemical compound CC(C)(C)C(=O)NCC(=O)OCCl MYFWDKSISWGFHK-UHFFFAOYSA-N 0.000 description 1
- IXBDTGGFRAKVNX-UHFFFAOYSA-N chloromethyl 4-(diethylamino)-4-oxobutanoate Chemical compound CCN(CC)C(=O)CCC(=O)OCCl IXBDTGGFRAKVNX-UHFFFAOYSA-N 0.000 description 1
- CHHRXILMDYFSNF-UHFFFAOYSA-N chloromethyl 4-(dimethylamino)-4-oxobutanoate Chemical compound CN(C)C(=O)CCC(=O)OCCl CHHRXILMDYFSNF-UHFFFAOYSA-N 0.000 description 1
- LORSXHZWVXQHJH-UHFFFAOYSA-N chloromethyl 4-(dipropylamino)-4-oxobutanoate Chemical compound CCCN(CCC)C(=O)CCC(=O)OCCl LORSXHZWVXQHJH-UHFFFAOYSA-N 0.000 description 1
- BOXZXICVMMSYPE-UHFFFAOYSA-N chloromethyl benzoate Chemical compound ClCOC(=O)C1=CC=CC=C1 BOXZXICVMMSYPE-UHFFFAOYSA-N 0.000 description 1
- 239000013058 crude material Substances 0.000 description 1
- 239000010779 crude oil Substances 0.000 description 1
- 125000006254 cycloalkyl carbonyl group Chemical group 0.000 description 1
- WEHWNAOGRSTTBQ-UHFFFAOYSA-N dipropylamine Chemical compound CCCNCCC WEHWNAOGRSTTBQ-UHFFFAOYSA-N 0.000 description 1
- 239000013583 drug formulation Substances 0.000 description 1
- 239000012156 elution solvent Substances 0.000 description 1
- 150000002084 enol ethers Chemical class 0.000 description 1
- KNWYAXZGBCCVDZ-UHFFFAOYSA-N ethyl 2-(2,2-dimethylpropanoylamino)acetate Chemical compound CCOC(=O)CNC(=O)C(C)(C)C KNWYAXZGBCCVDZ-UHFFFAOYSA-N 0.000 description 1
- MAOWFWDQHHSWHM-UHFFFAOYSA-N ethyl 2-(2-ethylbutanoylamino)acetate Chemical compound CCOC(=O)CNC(=O)C(CC)CC MAOWFWDQHHSWHM-UHFFFAOYSA-N 0.000 description 1
- SIKGPXZYZKGRIL-UHFFFAOYSA-N ethyl 2-[2-(dichloromethoxy)-2-oxoethoxy]acetate Chemical compound CCOC(=O)COCC(=O)OC(Cl)Cl SIKGPXZYZKGRIL-UHFFFAOYSA-N 0.000 description 1
- FCZCIXQGZOUIDN-UHFFFAOYSA-N ethyl 2-diethoxyphosphinothioyloxyacetate Chemical compound CCOC(=O)COP(=S)(OCC)OCC FCZCIXQGZOUIDN-UHFFFAOYSA-N 0.000 description 1
- IXZFDJXHLQQSGQ-UHFFFAOYSA-N ethyl 4-chloro-4-oxobutanoate Chemical compound CCOC(=O)CCC(Cl)=O IXZFDJXHLQQSGQ-UHFFFAOYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 125000001153 fluoro group Chemical group F* 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 210000001035 gastrointestinal tract Anatomy 0.000 description 1
- 125000005843 halogen group Chemical group 0.000 description 1
- 238000004128 high performance liquid chromatography Methods 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- XMBWDFGMSWQBCA-UHFFFAOYSA-N hydrogen iodide Chemical compound I XMBWDFGMSWQBCA-UHFFFAOYSA-N 0.000 description 1
- 238000005984 hydrogenation reaction Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-M hydroxide Chemical compound [OH-] XLYOFNOQVPJJNP-UHFFFAOYSA-M 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 239000012442 inert solvent Substances 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- XKBISHPFHZELKG-UHFFFAOYSA-N iodomethyl 2-(2,2-dimethylpropanoylamino)acetate Chemical compound CC(C)(C)C(=O)NCC(=O)OCI XKBISHPFHZELKG-UHFFFAOYSA-N 0.000 description 1
- IDIHIONJJPNMQI-UHFFFAOYSA-N iodomethyl 2-(2-ethylbutanoylamino)acetate Chemical compound CCC(CC)C(=O)NCC(=O)OCI IDIHIONJJPNMQI-UHFFFAOYSA-N 0.000 description 1
- WLPAMOBTRZZQPV-UHFFFAOYSA-N iodomethyl 2-(diethylcarbamoyloxy)acetate Chemical compound CCN(CC)C(=O)OCC(=O)OCI WLPAMOBTRZZQPV-UHFFFAOYSA-N 0.000 description 1
- PNWSPLKKVLZMHP-UHFFFAOYSA-N iodomethyl 2-(dimethylcarbamoyloxy)acetate Chemical compound CN(C)C(=O)OCC(=O)OCI PNWSPLKKVLZMHP-UHFFFAOYSA-N 0.000 description 1
- QYXQRRLWXZBSGJ-UHFFFAOYSA-N iodomethyl 4-(diethylamino)-4-oxobutanoate Chemical compound CCN(CC)C(=O)CCC(=O)OCI QYXQRRLWXZBSGJ-UHFFFAOYSA-N 0.000 description 1
- KYXUBZSBLGVOQG-UHFFFAOYSA-N iodomethyl 4-(dimethylamino)-4-oxobutanoate Chemical compound CN(C)C(=O)CCC(=O)OCI KYXUBZSBLGVOQG-UHFFFAOYSA-N 0.000 description 1
- NDJPBTNFCNBLFW-UHFFFAOYSA-N iodomethyl 4-(dipropylamino)-4-oxobutanoate Chemical compound CCCN(CCC)C(=O)CCC(=O)OCI NDJPBTNFCNBLFW-UHFFFAOYSA-N 0.000 description 1
- 150000002596 lactones Chemical group 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- VNWKTOKETHGBQD-UHFFFAOYSA-N methane Natural products C VNWKTOKETHGBQD-UHFFFAOYSA-N 0.000 description 1
- 229940098779 methanesulfonic acid Drugs 0.000 description 1
- JHDQHPJHLHKZDL-UHFFFAOYSA-N methyl 4-chloro-4-oxobut-2-enoate Chemical compound COC(=O)C=CC(Cl)=O JHDQHPJHLHKZDL-UHFFFAOYSA-N 0.000 description 1
- SRXOJMOGPYFZKC-UHFFFAOYSA-N methyl 4-chloro-4-oxobutanoate Chemical compound COC(=O)CCC(Cl)=O SRXOJMOGPYFZKC-UHFFFAOYSA-N 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- RZCCQWOCSZOHMQ-UHFFFAOYSA-N n,n-diethyl-2-hydroxyacetamide Chemical compound CCN(CC)C(=O)CO RZCCQWOCSZOHMQ-UHFFFAOYSA-N 0.000 description 1
- OFCCYDUUBNUJIB-UHFFFAOYSA-N n,n-diethylcarbamoyl chloride Chemical compound CCN(CC)C(Cl)=O OFCCYDUUBNUJIB-UHFFFAOYSA-N 0.000 description 1
- XRPITCBWOUOJTH-UHFFFAOYSA-N n,n-diethylpyridin-2-amine Chemical compound CCN(CC)C1=CC=CC=N1 XRPITCBWOUOJTH-UHFFFAOYSA-N 0.000 description 1
- 239000000041 non-steroidal anti-inflammatory agent Substances 0.000 description 1
- REEZZSHJLXOIHL-UHFFFAOYSA-N octanoyl chloride Chemical compound CCCCCCCC(Cl)=O REEZZSHJLXOIHL-UHFFFAOYSA-N 0.000 description 1
- 239000012074 organic phase Substances 0.000 description 1
- 150000005623 oxindoles Chemical class 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- UYWQUFXKFGHYNT-UHFFFAOYSA-N phenylmethyl ester of formic acid Natural products O=COCC1=CC=CC=C1 UYWQUFXKFGHYNT-UHFFFAOYSA-N 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 230000036470 plasma concentration Effects 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- AHIHJODVQGBOND-UHFFFAOYSA-N propan-2-yl hydrogen carbonate Chemical compound CC(C)OC(O)=O AHIHJODVQGBOND-UHFFFAOYSA-N 0.000 description 1
- ATBIAJXSKNPHEI-UHFFFAOYSA-N pyridine-3-carbonyl chloride Chemical compound ClC(=O)C1=CC=CN=C1 ATBIAJXSKNPHEI-UHFFFAOYSA-N 0.000 description 1
- RVQZKNOMKUSGCI-UHFFFAOYSA-N pyridine-4-carbonyl chloride Chemical compound ClC(=O)C1=CC=NC=C1 RVQZKNOMKUSGCI-UHFFFAOYSA-N 0.000 description 1
- 150000003856 quaternary ammonium compounds Chemical class 0.000 description 1
- 125000001453 quaternary ammonium group Chemical group 0.000 description 1
- 239000000376 reactant Substances 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 239000012047 saturated solution Substances 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- UCXONOZQZVZULD-UHFFFAOYSA-M sodium;2-(2,2-dimethylpropanoylamino)acetate Chemical compound [Na+].CC(C)(C)C(=O)NCC([O-])=O UCXONOZQZVZULD-UHFFFAOYSA-M 0.000 description 1
- LZIOYZXMEFKXMW-UHFFFAOYSA-M sodium;2-(2-ethylbutanoylamino)acetate Chemical compound [Na+].CCC(CC)C(=O)NCC([O-])=O LZIOYZXMEFKXMW-UHFFFAOYSA-M 0.000 description 1
- 238000000935 solvent evaporation Methods 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- QQWYQAQQADNEIC-RVDMUPIBSA-N tert-butyl [(z)-[cyano(phenyl)methylidene]amino] carbonate Chemical compound CC(C)(C)OC(=O)O\N=C(/C#N)C1=CC=CC=C1 QQWYQAQQADNEIC-RVDMUPIBSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- JOXIMZWYDAKGHI-UHFFFAOYSA-N toluene-4-sulfonic acid Chemical compound CC1=CC=C(S(O)(=O)=O)C=C1 JOXIMZWYDAKGHI-UHFFFAOYSA-N 0.000 description 1
- IMFACGCPASFAPR-UHFFFAOYSA-N tributylamine Chemical compound CCCCN(CCCC)CCCC IMFACGCPASFAPR-UHFFFAOYSA-N 0.000 description 1
- ILWRPSCZWQJDMK-UHFFFAOYSA-N triethylazanium;chloride Chemical compound Cl.CCN(CC)CC ILWRPSCZWQJDMK-UHFFFAOYSA-N 0.000 description 1
- 238000000825 ultraviolet detection Methods 0.000 description 1
- 229940005605 valeric acid Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F7/00—Compounds containing elements of Groups 4 or 14 of the Periodic Table
- C07F7/02—Silicon compounds
- C07F7/08—Compounds having one or more C—Si linkages
- C07F7/18—Compounds having one or more C—Si linkages as well as one or more C—O—Si linkages
- C07F7/1804—Compounds having Si-O-C linkages
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pain & Pain Management (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/009,188 US5270331A (en) | 1993-01-26 | 1993-01-26 | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| IL108384A0 IL108384A0 (en) | 1994-04-12 |
| IL108384A true IL108384A (en) | 1998-12-27 |
Family
ID=21736103
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL10838494A IL108384A (en) | 1993-01-26 | 1994-01-20 | 3-Noble-2-oxindole-1-oxindole-1-carboxoxamide anti-inflammatory drugs and uses thereof |
Country Status (35)
| Country | Link |
|---|---|
| US (1) | US5270331A (ko) |
| EP (1) | EP0681580B1 (ko) |
| JP (1) | JP2703825B2 (ko) |
| KR (1) | KR0169827B1 (ko) |
| CN (1) | CN1052003C (ko) |
| AP (1) | AP443A (ko) |
| AT (1) | ATE155137T1 (ko) |
| AU (1) | AU678187B2 (ko) |
| BR (1) | BR9307768A (ko) |
| CA (1) | CA2152919C (ko) |
| CZ (1) | CZ181995A3 (ko) |
| DE (1) | DE69312093T2 (ko) |
| DK (1) | DK0681580T3 (ko) |
| EG (1) | EG20302A (ko) |
| ES (1) | ES2104187T3 (ko) |
| FI (1) | FI940365A (ko) |
| GR (1) | GR3024591T3 (ko) |
| HR (1) | HRP940034B1 (ko) |
| HU (1) | HUT69689A (ko) |
| IL (1) | IL108384A (ko) |
| MA (1) | MA23096A1 (ko) |
| MX (1) | MX9400677A (ko) |
| MY (1) | MY138629A (ko) |
| NO (1) | NO952949D0 (ko) |
| NZ (1) | NZ257278A (ko) |
| OA (1) | OA10563A (ko) |
| PL (1) | PL178857B1 (ko) |
| RU (1) | RU2124514C1 (ko) |
| SI (1) | SI9300567A (ko) |
| SK (1) | SK280929B6 (ko) |
| TW (1) | TW330935B (ko) |
| UA (1) | UA41348C2 (ko) |
| WO (1) | WO1994017061A1 (ko) |
| YU (1) | YU48796B (ko) |
| ZA (1) | ZA94463B (ko) |
Families Citing this family (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2155664C (en) * | 1993-02-09 | 1999-06-15 | Ralph P. Robinson | Oxindole 1-[n-(alkoxycarbonyl)]carboxamides and 1-(n-carboxamido)carboxamides as antiinflammatory agents |
| WO1997013767A1 (de) * | 1995-10-09 | 1997-04-17 | Chemisch Pharmazeutische Forschungsgesellschaft Mbh | Heterocyclisch substituierte 1-indolcarboxamide als cyclooxygenase-2 inhibitoren |
| WO1999044608A1 (en) * | 1998-03-06 | 1999-09-10 | Astrazeneca Ab | New use |
| EP0984012A3 (en) * | 1998-08-31 | 2001-01-10 | Pfizer Products Inc. | Nitric oxide releasing oxindole prodrugs with analgesic and anti-inflammatory properties |
| AU2002325614A1 (en) * | 2001-08-16 | 2003-03-03 | Pharmacon-Forschung Und Beratung Gmbh | Compounds containing lactic acid elements, method for the production and use thereof as pharmaceutically active substances |
| CN101628842A (zh) * | 2009-08-27 | 2010-01-20 | 中国人民解放军防化指挥工程学院 | 烷氧羰基甲氧基作为羧基保护基 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4556672A (en) * | 1984-03-19 | 1985-12-03 | Pfizer Inc. | 3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents |
| DE68923673T2 (de) * | 1988-10-18 | 1996-01-18 | Pfizer | Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden. |
| HU208421B (en) * | 1988-10-18 | 1993-10-28 | Pfizer | Process for producing starting materials for producing 3-acyl-2-oxindol-carboxamides ofantiphlogistic activity |
-
1993
- 1993-01-26 US US08/009,188 patent/US5270331A/en not_active Expired - Lifetime
- 1993-10-13 TW TW082108483A patent/TW330935B/zh active
- 1993-10-20 AT AT93923879T patent/ATE155137T1/de not_active IP Right Cessation
- 1993-10-20 JP JP6511478A patent/JP2703825B2/ja not_active Expired - Fee Related
- 1993-10-20 DK DK93923879.6T patent/DK0681580T3/da active
- 1993-10-20 UA UA95073512A patent/UA41348C2/uk unknown
- 1993-10-20 WO PCT/US1993/009813 patent/WO1994017061A1/en active IP Right Grant
- 1993-10-20 BR BR9307768A patent/BR9307768A/pt not_active Application Discontinuation
- 1993-10-20 DE DE69312093T patent/DE69312093T2/de not_active Expired - Fee Related
- 1993-10-20 AU AU53598/94A patent/AU678187B2/en not_active Ceased
- 1993-10-20 EP EP93923879A patent/EP0681580B1/en not_active Expired - Lifetime
- 1993-10-20 PL PL93309989A patent/PL178857B1/pl not_active IP Right Cessation
- 1993-10-20 CZ CZ951819A patent/CZ181995A3/cs not_active IP Right Cessation
- 1993-10-20 RU RU95117091A patent/RU2124514C1/ru not_active IP Right Cessation
- 1993-10-20 ES ES93923879T patent/ES2104187T3/es not_active Expired - Lifetime
- 1993-10-20 NZ NZ257278A patent/NZ257278A/en unknown
- 1993-10-20 SK SK912-95A patent/SK280929B6/sk unknown
- 1993-10-20 CA CA002152919A patent/CA2152919C/en not_active Expired - Fee Related
- 1993-10-21 AP APAP/P/1993/000583A patent/AP443A/en active
- 1993-10-28 SI SI9300567A patent/SI9300567A/sl not_active IP Right Cessation
-
1994
- 1994-01-16 EG EG2694A patent/EG20302A/xx active
- 1994-01-18 MY MYPI94000137A patent/MY138629A/en unknown
- 1994-01-20 IL IL10838494A patent/IL108384A/en not_active IP Right Cessation
- 1994-01-21 HR HR940034A patent/HRP940034B1/xx not_active IP Right Cessation
- 1994-01-24 ZA ZA94463A patent/ZA94463B/xx unknown
- 1994-01-25 HU HU9400209A patent/HUT69689A/hu unknown
- 1994-01-25 FI FI940365A patent/FI940365A/fi not_active Application Discontinuation
- 1994-01-25 MX MX9400677A patent/MX9400677A/es not_active IP Right Cessation
- 1994-01-25 MA MA23402A patent/MA23096A1/fr unknown
- 1994-01-25 YU YU2994A patent/YU48796B/sh unknown
- 1994-01-25 CN CN94100697A patent/CN1052003C/zh not_active Expired - Fee Related
-
1995
- 1995-07-25 OA OA60692A patent/OA10563A/en unknown
- 1995-07-25 NO NO952949A patent/NO952949D0/no unknown
- 1995-07-26 KR KR1019950703074A patent/KR0169827B1/ko not_active IP Right Cessation
-
1997
- 1997-09-02 GR GR970402235T patent/GR3024591T3/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| KR102548191B1 (ko) | 표적 단백질 분해 화합물, 이의 항종양 응용, 이의 중간체 및 중간체의 응용 | |
| SK150398A3 (en) | Indole derivatives useful as endothelin receptor antagonists | |
| HU223752B1 (hu) | A gasztrointesztinális keringést elősegítő gyógyászati készítmény | |
| JPH08507049A (ja) | 低脂血症性化合物１，４−チアゼピン | |
| FR3008978A1 (fr) | "nouveaux derives d'indole et de pyrrole, leur procede de preparation et les compositions pharmaceutiques qui les contiennent" | |
| US6281228B1 (en) | Heterocyclic inhibitors of microsomal triglyceride transfer protein and method | |
| JP2010536736A (ja) | ３位において二置換されているインドール−２−オン誘導体、これらの調製およびこれらの治療上の使用 | |
| NZ279265A (en) | Crystalline tripeptide derivative and medicaments | |
| KR0130899B1 (ko) | 인돌일피페리딘 화합물, 그 제조방법 및 그들을 함유하는 약학조성물 | |
| WO2023034946A1 (en) | Indole compounds and uses thereof in the treatement of cystic fibrosis | |
| AU2014295101A1 (en) | New isoindoline or isoquinoline compounds, a process for their preparation and pharmaceutical compositions containing them | |
| AU678187B2 (en) | Prodrugs of antiinflammatory 3-acyl-2-oxindole-1-carboxamides | |
| JPH10508311A (ja) | スピロ［複素環−イミダゾ［１，２−ａ］インデノ［１，２−ｅ］ピラジン］−４’−オン類、これらの調製、及びこれらを含んでいる医薬品 | |
| JPS59212489A (ja) | Ｎ−ピリジンインド−ル及びその製造方法並びにこの化合物を含有する医薬 | |
| RU2446166C2 (ru) | Гетероциклические соединения, имеющие сродство к мускариновым рецепторам | |
| FR2758329A1 (fr) | Derives d'imidazole-4-butane boronique, leur preparation et leur utilisation en therapeutique | |
| JP2663794B2 (ja) | 複素環誘導体 | |
| WO1998042710A1 (fr) | Derives de dihydropyrazino[1,2-a]indole-1-one, leur preparation et leur application en therapeutique | |
| JPH07503969A (ja) | テストステロン５α−還元酵素阻害剤としてのインドール誘導体 | |
| ES2288795B1 (es) | Compuestos antitumorales. | |
| JP2009517351A (ja) | 化学物質 | |
| MXPA02005560A (es) | Bisindolilmaleimidas sustituidas para la inhibicion de proliferacion celular. | |
| JPH02149589A (ja) | 新規なアスパルテートトランスカルバミラーゼ抑制剤類 | |
| JP2022524294A (ja) | デュオカルマイシン類似体 | |
| WO1996033158A1 (fr) | Nouveau derive d'×strogenes dirige sur les tissus osseux |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FF | Patent granted | ||
| KB | Patent renewed | ||
| FF | Patent granted | ||
| KB | Patent renewed | ||
| MM9K | Patent not in force due to non-payment of renewal fees |